Golden Ally Lifetech Group, Inc. (AQPW) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.25: the stock has moved about 25% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGolden Ally Lifetech Group, Inc. (AQPW) trades at $0.0001. Golden Ally Lifetech Group, Inc. is a development stage company focused on advanced technologies, energy solutions, and medical devices. Sector: Consumer defensive.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for AQPW: AQPW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AQPW against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
AQPW: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Golden Ally Lifetech Group, Inc. (AQPW) Consumer Business Overview
Golden Ally Lifetech Group, Inc., operating in the consumer defensive sector, is in the development stage, concentrating on bioscience, sport medicines, energy solutions, and graphene applications. Its diverse product pipeline, including self-sanitizing devices and energy solutions, positions it within the non-alcoholic beverages industry, albeit with a broader technology focus.
What Is the Investment Thesis for AQPW?
Golden Ally Lifetech Group, Inc. presents a speculative investment opportunity given its development stage status and focus on emerging technologies. Key value drivers include successful commercialization of its Sterilal self-sanitizing devices, PASS smart denture mouth guards, and InCharge energy solutions. The company's ability to secure partnerships and funding for its graphene de-icing application could also drive growth. However, the company's limited operating history, OTC market listing, and lack of revenue generation pose significant risks. Investors should carefully consider the high level of uncertainty and potential for dilution before investing. The company's beta of 1.25 indicates higher volatility compared to the market.
Based on FMP financials and quantitative analysis
AQPW Key Highlights
Golden Ally Lifetech Group, Inc. is a development stage company focused on bioscience, sport medicines, energy solutions, and graphene applications.
- The company's product pipeline includes Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems.
- Golden Ally Lifetech is developing the InCharge magnetic-based battery device for energy solutions.
- The company is exploring the application of graphene for de-icing in the airline industry.
- Golden Ally Lifetech Group, Inc. trades on the OTC market, indicating higher risk and lower liquidity.
Who Are AQPW's Competitors?
AQPW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BNKK Bonk, Inc. | $1.36 | -6.85% | $10.9M | — |
| BRFH Barfresh Food Group, Inc. | $1.23 | -2.78% | $19.8M | — |
| ZVIA Zevia PBC | $1.25 | +1.21% | $90.1M | 345-pillar |
| BUDA Buda Juice Inc. | $7.99 | 0.00% | $100M | 745-pillar |
| OTLY Oatly Group AB | $12.53 | -0.63% | $391M | — |
| FIZZ National Beverage Corp. | $30.91 | +1.21% | $2.89B | 845-pillar |
| COCO The Vita Coco Company, Inc. | $51.85 | +1.47% | $2.98B | 885-pillar |
| CELH Celsius Holdings, Inc. | $27.51 | +3.30% | $7.03B | 635-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AQPW's Key Strengths?
Innovative technologies in bioscience, energy, and materials science.
- Diverse product pipeline with potential for multiple revenue streams.
- Experienced management team with expertise in technology development.
- Strategic partnerships with established companies.
What Are AQPW's Weaknesses?
Development stage company with limited operating history.
- Dependence on external funding for research and development.
- OTC market listing with limited liquidity and higher risk.
- Lack of revenue generation and profitability.
What Could Drive AQPW Stock Higher?
Successful completion of clinical trials for PASS smart denture mouth guards.
- Securing partnerships for distribution of Sterilal self-sanitizing devices.
- Positive results from testing of graphene de-icing application in the airline industry.
- Development and commercialization of InCharge magnetic-based battery device.
- Exploration of strategic partnerships and acquisitions to expand product portfolio.
What Are the Key Risks for AQPW?
Financial-distress signal — its Altman Z-Score of -23.91 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited operating history and lack of revenue generation.
- Dependence on external funding for research and development.
- OTC market listing with limited liquidity and higher risk.
- Competition from established companies with greater resources.
- Regulatory hurdles and lengthy approval processes.
What Are the Growth Opportunities for AQPW?
- Commercialization of Sterilal Self-Sanitizing Devices: The market for self-sanitizing devices is expanding due to increased health awareness. Golden Ally Lifetech's Sterilal device has the potential to capture a significant share of this market. Successful commercialization and distribution partnerships could drive revenue growth within the next 1-2 years. The global sanitization market is projected to reach $15 billion by 2028, offering a substantial opportunity for AQPW.
- Development and Launch of PASS Smart Denture Mouth Guards: The market for dental health products is consistently growing, with an increasing focus on preventative care. The PASS smart denture mouth guard could appeal to a specific segment of the population seeking advanced oral health solutions. Successful product development and clinical trials could lead to commercialization within 2-3 years, contributing to revenue diversification. The global dental market is expected to reach $55 billion by 2027.
- Advancement of InCharge Magnetic-Based Battery Device: The demand for portable and efficient energy solutions is rising, driven by the increasing use of mobile devices and electric vehicles. Golden Ally Lifetech's InCharge device has the potential to address this demand with its magnetic-based technology. Further development and strategic partnerships could lead to commercialization within 2-3 years, expanding the company's presence in the energy sector. The global portable power station market is projected to reach $30 billion by 2028.
- Graphene De-Icing Application for the Airline Industry: The airline industry is constantly seeking innovative solutions to improve efficiency and safety. Golden Ally Lifetech's graphene de-icing application has the potential to address this need. Successful testing and partnerships with airlines could lead to commercial adoption within 3-5 years, creating a new revenue stream for the company.
- Strategic Partnerships and Acquisitions: Golden Ally Lifetech can pursue strategic partnerships with established companies in the medical device, energy, and airline industries to accelerate the development and commercialization of its technologies. Acquisitions of complementary technologies or companies could also expand its product portfolio and market reach. These partnerships and acquisitions could be pursued within the next 1-3 years, contributing to long-term growth and value creation.
What Threats Does AQPW Face?
- Competition from established companies with greater resources.
- Regulatory hurdles and lengthy approval processes.
- Technological obsolescence and rapid innovation.
- Economic downturn and reduced consumer spending.
What Are AQPW's Competitive Advantages?
- Proprietary technologies in bioscience, energy, and materials science.
- Potential for patents and intellectual property protection.
- First-mover advantage in niche markets.
- Strategic partnerships with established companies.
What Does AQPW Do?
Golden Ally Lifetech Group, Inc., established in 2003 and based in Austin, Texas, is a development stage company focused on creating advanced technologies, energy solutions, and medical devices. Originally named Signet International Holdings, Inc., the company rebranded in July 2022 to reflect its evolving focus. The company's core business revolves around the development of innovative products in bioscience and sports medicine. These include Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems. Beyond medical applications, Golden Ally Lifetech is also developing the InCharge magnetic-based battery device for energy solutions. Additionally, the company explores the application of graphene for de-icing in the airline industry, showcasing its commitment to diverse technological advancements. As a development stage company, Golden Ally Lifetech is currently focused on research, development, and commercialization of its technologies.
What Products and Services Does AQPW Offer?
- Develop advanced technologies in bioscience and sport medicines.
- Create self-sanitizing devices for various applications.
- Design smart denture mouth guards for improved oral health.
- Develop handheld heart attack sensors for early detection.
- Create melanoma detection systems for skin cancer screening.
- Offer magnetic-based battery devices for energy solutions.
- Develop graphene applications for de-icing in the airline industry.
How Does AQPW Make Money?
- Develop and commercialize innovative technologies in bioscience, energy, and materials science.
- Generate revenue through the sale of products and licensing of technologies.
- Seek partnerships with established companies for distribution and commercialization.
- Explore government grants and funding opportunities to support research and development.
What Industry Does AQPW Operate In?
Golden Ally Lifetech Group, Inc. operates within the consumer defensive sector, specifically targeting the non-alcoholic beverages industry with its energy solutions and advanced technologies. The company's focus on bioscience and sport medicines places it in a niche market with potential for growth. The competitive landscape includes companies like ALKM, BLEG, DZGH, EESO, and FBEC, which are also exploring innovative solutions in the beverage and related industries. The market for advanced technologies and energy solutions is expected to grow, driven by increasing demand for sustainable and efficient products.
Who Are AQPW's Key Customers?
- Healthcare providers seeking advanced diagnostic and treatment solutions.
- Athletes and sports enthusiasts looking for performance-enhancing and protective devices.
- Consumers seeking convenient and effective energy solutions.
- Airlines seeking innovative de-icing solutions to improve efficiency and safety.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 20 snapshots
| 2026-08-23 | 47 |
| 2026-08-27 | 47 |
| 2026-08-31 | 47 |
| 2026-09-04 | 47 |
| 2026-09-08 | 47 |
| 2026-09-11 | 47 |
What changed?
The score has stayed at 47.
Over the same 19 days the stock moved +0.0%.
Company Profile
Golden Ally Lifetech Group, Inc. operates in the Beverages - Non-Alcoholic industry within the Consumer Defensive sector. It is headquartered in Austin, US. The company is led by CEO Oliver Keren Ban. AQPW has traded publicly since 2007.
Financial Health
Golden Ally Lifetech Group, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -23.91 places it in the distress zone, a signal of elevated financial risk.
AQPW Financials
Bull Case vs Bear Case
Bull Case
- Innovative technologies in bioscience, energy, and materials science.
- Diverse product pipeline with potential for multiple revenue streams.
- Experienced management team with expertise in technology development.
- Strategic partnerships with established companies.
Bear Case
- Development stage company with limited operating history.
- Dependence on external funding for research and development.
- OTC market listing with limited liquidity and higher risk.
- Lack of revenue generation and profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
AQPW Latest News
No recent news available for AQPW.
AQPW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AQPW.
Price Targets
Wall Street price target analysis for AQPW.
AQPW MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AQPW; grades run from A+ (80-100) to F (below 30).
Leadership: Oliver Keren Ban
CEO
Oliver Keren Ban serves as the CEO of Golden Ally Lifetech Group, Inc. His background includes experience in managing and developing technology-focused companies. He has been involved in various aspects of business development, including strategic planning, financial management, and product development. His leadership aims to drive innovation and commercialization of the company's diverse product pipeline.
Track Record: Under Oliver Keren Ban's leadership, Golden Ally Lifetech Group, Inc. has focused on developing advanced technologies in bioscience, energy solutions, and medical devices. Key milestones include the development of Sterilal self-sanitizing devices, PASS smart denture mouth guards, and InCharge magnetic-based battery device. The company has also explored the application of graphene for de-icing in the airline industry.
AQPW OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Golden Ally Lifetech Group, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may be subject to greater price volatility. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing.
- OTC Tier: OTC Other
- Limited liquidity and wider bid-ask spreads.
- Lack of regulatory oversight and potential for fraud or manipulation.
- Limited financial disclosure and transparency.
- Higher price volatility and risk of significant losses.
- Potential for dilution through stock offerings.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's intellectual property and patent portfolio.
- Review the company's legal and regulatory compliance.
- Monitor the company's trading volume and price activity.
- Consult with a qualified financial advisor.
- Company has a registered business address and contact information.
- Company has a functional website with information about its products and services.
- Company has a management team with relevant experience.
- Company has a clear business plan and strategy.
- Company has secured partnerships or funding from reputable sources.
Golden Ally Lifetech Group, Inc. Consumer Defensive Stock: Key Questions Answered
Is AQPW a good stock?
Stock Expert AI does not rate AQPW buy, sell or hold. Golden Ally Lifetech Group, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about AQPW stock?
As of 2026-03-17, there is no readily available analyst coverage specifically for Golden Ally Lifetech Group, Inc. (AQPW). Given its OTC listing and development stage status, the stock is likely not widely followed by major brokerage firms.
What are the main risks for AQPW?
Investing in Golden Ally Lifetech Group, Inc. carries significant risks due to its development stage status, OTC market listing, and limited financial disclosure. The illiquidity of OTC stocks can make it difficult to buy or sell shares at desired prices.
What are the key factors to evaluate for AQPW?
Evaluate AQPW on fundamentals, analyst consensus, and risk factors. The company's ability to secure partnerships and funding for its graphene de-icing application could also drive growth. Not financial advice.
How frequently does AQPW data refresh on this page?
AQPW's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.
What has driven AQPW's recent stock price performance?
Golden Ally Lifetech Group, Inc. (AQPW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative technologies in bioscience, energy, and materials science. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AQPW overvalued or undervalued right now?
Golden Ally Lifetech Group, Inc. (AQPW) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of AQPW?
Yes, most major brokerages offer fractional shares of Golden Ally Lifetech Group, Inc. (AQPW) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on limited data available for this OTC-listed company.